Udawela Madhara, Hay Debbie L, Sexton Patrick M
Molecular Pharmacology Group, Howard Florey Institute, The University of Melbourne, Gate 11, Royal Parade, Melbourne, Vic. 3010, Australia.
Semin Cell Dev Biol. 2004 Jun;15(3):299-308. doi: 10.1016/j.semcdb.2003.12.019.
Receptor diversity for the calcitonin peptide family is created by the interaction of two 7-transmembrane proteins--the calcitonin receptor (CTR) or the calcitonin receptor-like receptor (CL-R)--with the receptor activity modifying protein (RAMP) family. The discovery of heterodimeric complexes of these proteins heralded a new era in the study of G protein coupled receptors (GPCRs), whereby receptor phenotype is no longer governed by just the GPCR. In this article, recent advances in the study of RAMPs are discussed--from our current understanding of the molecular basis of RAMP-receptor interaction to a broader role for RAMPs outside the calcitonin receptor family.
降钙素肽家族的受体多样性是由两种7跨膜蛋白——降钙素受体(CTR)或降钙素受体样受体(CL-R)——与受体活性修饰蛋白(RAMP)家族相互作用产生的。这些蛋白异二聚体复合物的发现开创了G蛋白偶联受体(GPCR)研究的新纪元,即受体表型不再仅由GPCR决定。本文讨论了RAMP研究的最新进展——从我们目前对RAMP-受体相互作用分子基础的理解到RAMP在降钙素受体家族之外更广泛的作用。